(Q43182469)

15 November 2017

A model-based approach to dose selection in early pediatric development (English)

1 reference

15 November 2017

M Cella

1

1 reference

15 November 2017

F Gorter de Vries

2

1 reference

15 November 2017

D Burger

3

1 reference

15 November 2017

M Danhof

4

1 reference

15 November 2017

O Della Pasqua

5

1 reference

15 November 2017

language of work or name

English

0 references

publication date

27 January 2010

1 reference

Clinical Pharmacology & Therapeutics

15 November 2017

1 reference

15 November 2017

87

1 reference

15 November 2017

3

1 reference

15 November 2017

294-302

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2009.234

15 November 2017

0 references

cites work

Mechanism-based concepts of size and maturity in pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Clinical trials in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Abacavir pharmacokinetics in human immunodeficiency virus-infected children ranging in age from 1 month to 16 years: a population analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Abacavir/lamividune combination in the treatment of HIV-1 infection: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Bayesian parameter estimation and population pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Population pharmacokinetics and pharmacodynamic modeling of abacavir (1592U89) from a dose-ranging, double-blind, randomized monotherapy trial with human immunodeficiency virus-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Use of prior information to stabilize a population data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Linking preclinical and clinical whole-body physiologically based pharmacokinetic models with prior distributions in NONMEM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Perl-speaks-NONMEM (PsN)--a Perl module for NONMEM related programming

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

Abacavir: absolute bioavailability, bioequivalence of three oral formulations, and effect of food

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

inferred from DOI database lookup

7 January 2021

based on heuristic

Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.234

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CLPT.2009.234

1 reference

Dimensions Publication ID

15 November 2017

0 references

1 reference